HEALTHDAILY MAIL
Hope for thousands of ovarian cancer patients as new drug which slashes risk of death by a third is made available on the NHS
A new drug that reduces the risk of death by a third for ovarian cancer patients is now available on the NHS, offering hope to thousands. The treatment marks a significant advancement in ovarian cancer care.
Related Signal
Adjacent reporting
- Life-prolonging drug for advanced ovarian cancer gets go-ahead in England
- Breakthrough ovarian cancer drug offers patients more time and better quality of life
- Repurposed drug may extend survival in aggressive ovarian cancer, trial shows
- GSK reports promising early results in ovarian and womb cancer drug trial
- Common cholesterol drug could help treat ovarian cancer, promising new research suggests
- Common cholesterol drug could help treat ovarian cancer, promising new research suggests